Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological..., 2022, Compagnoa et al

Andy

Retired committee member
Full title: Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological - based rehabilitation program

Abstract
Background
Long Covid Syndrome (LCS) is used to describe signs and symptoms that continue or develop after acute COVID-19 infection. Natural history and treatment of this syndrome are still poorly understood, even if evidences suggest the potential role of physical rehabilitation in improving symptoms in these patients.

Aim of the study
The aim of the present study was to evaluate effectiveness, safety and feasibility of an out-of-hospital multidisciplinary rehabilitation (MDR) program, based both on physical and psychological reconditioning, in reducing symptoms and improving physical fitness and psychological parameters in patients with LCS.

Methods
Thirty consecutive patients with LCS (18 males, mean age 58 years) underwent an accurate medical screening process including anthropometric and muscular strength evaluation, cardiopulmonary exercise test, quality of life (QoL) and psychological appraisal before and after a MDR program.

Results
At baseline, all LCS patients were strongly symptomatic and showed severe impairments in physical performance, QoL and psychological parameters. No adverse effects and dropouts were observed during the exercise training sessions. After the MDR program, COVID-19 residual symptoms significantly decreased, and significant improvements in upper and lower limb muscular strength, cardiopulmonary parameters, perceived physical and mental health, depression and anxiety were observed.

Conclusions
The present study confirms the severe physical and psychological impairment of patients with LCS and suggests that a MDR program is effective, safe and feasible in these patients and could promote their physical and psychological recovery.

Open access, https://www.sciencedirect.com/science/article/pii/S2352906722001294
 
No mention I could see anywhere if PEM in any of the patients. They don't seem to be a good representative sample of Long Covid patients, with the majority having been hospitalised, and a high proportion of obese and smokers, and mean age close to 60. Adverse events were defined solely as heart problems, so no recording of PEM if any suffered from it. Also they were in the study quite soon after getting Covid, so might well have recovered anyway. And no control group.

I don't think this tells us anything useful about these treatments for Long covid.
 
Back
Top Bottom